Stock EW EDWARDS LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Edwards Lifesciences Corporation Stock

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse
Other stock markets
 04:00:02 2024-07-02 pm EDT 		5-day change 1st Jan Change
91.23 USD +1.09% Intraday chart for Edwards Lifesciences Corporation +0.16% +19.65%
Jul. 02 Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating MT
Jun. 20 Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing MT

Financials (USD)

Sales 2024 * 6.56B Sales 2025 * 7.17B Capitalization 54.98B
Net income 2024 * 1.61B Net income 2025 * 1.88B EV / Sales 2024 * 8.12 x
Net cash position 2024 * 1.67B Net cash position 2025 * 2.8B EV / Sales 2025 * 7.27 x
P/E ratio 2024 *
34.5 x
P/E ratio 2025 *
29.4 x
Employees 19,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.59%
More Fundamentals * Assessed data

Chart Edwards Lifesciences Corporation

Dynamic Chart

Latest news about Edwards Lifesciences Corporation

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating MT
Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing MT
Edwards Lifesciences Corporation Announces Executive Changes CI
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75 MT
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus CI
Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM
Transcript : Edwards Lifesciences Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 12:00 PM
Sector Update: Health Care Stocks Steady Premarket Monday MT
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion. CI
Some of the biggest splits in Corporate America RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 MT
More news

Latest transcript on Edwards Lifesciences Corporation

Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM
More transcripts

Analyst Recommendations on Edwards Lifesciences Corporation

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating MT
Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing MT
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75 MT
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 MT
More recommendations

Press releases Edwards Lifesciences Corporation

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR BU
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader PR
Edwards Lifesciences to Sell Critical Care to BD BU
Edwards Lifesciences : Charter of the Audit Committee PU
Edwards Lifesciences : First Quarter 2024 Fact Sheet PU
More press releases

News in other languages on Edwards Lifesciences Corporation

Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison
EE.UU. - Valores a seguir en Wall Street (actualizado)
Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité
More news

Quotes and Performance

1 day+1.09%
1 week+1.18%
Current month-1.23%
1 month+4.99%
3 months-3.20%
6 months+19.65%
Current year+19.65%
More quotes

Highs and lows

1 week
89.80
Extreme 89.8
93.99
1 month
85.12
Extreme 85.12
93.99
Current year
71.67
Extreme 71.67
96.12
1 year
60.57
Extreme 60.57
96.12
3 years
60.57
Extreme 60.57
131.73
5 years
51.51
Extreme 51.5067
131.73
10 years
14.01
Extreme 14.0083
131.73
More quotes

Managers and Directors - Edwards Lifesciences Corporation

Managers TitleAgeSince
Bernard Zovighian CEO
 Chief Executive Officer 56 14-12-31
Scott Ullem DFI
 Director of Finance/CFO 57 13-12-31
Todd Brinton CTO
 Chief Tech/Sci/R&D Officer - 19-01-31
Members of the board TitleAgeSince
Leslie Heisz BRD
 Director/Board Member 63 16-07-04
Nicholas Valeriani CHM
 Chairman 67 14-11-12
Steven Loranger BRD
 Director/Board Member 72 16-03-15
More insiders

ETFs positioned on Edwards Lifesciences Corporation

Name Weight AuM 1st Jan change Investor Rating
BMO US PUT WRITE ETF - CAD ETF BMO US Put Write ETF - CAD
2.46% 43 M€ -0.19% -
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
2.34% 21 M€ +9.74% -
BMO PREMIUM YIELD ETF - CAD HEDGED ETF BMO Premium Yield ETF - CAD Hedged
1.17% 24 M€ -0.07% -
More ETFs positioned on Edwards Lifesciences Corporation

Quotes

Date Price Change Volume
24-07-02 91.23 +1.09% 1,899,408
24-07-01 90.25 -2.30% 3,277,669
24-06-28 92.37 -1.04% 11,670,925
24-06-27 93.34 +1.94% 3,309,489
24-06-26 91.56 +0.53% 2,854,523

Delayed Quote Nyse, July 02, 2024 at 04:00 pm EDT

More quotes

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
Advanced Medical Equipment & Technology
Calendar
2024-07-24 - Q2 2024 Earnings Release (Projected)
Related indices
S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.23 USD
Average target price
96.13 USD
Spread / Average Target
+5.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+19.65% 54.38B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+0.59% 207B
DANAHER CORPORATION Stock Danaher Corporation
+3.92% 181B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+30.07% 155B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+32.42% 112B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.98% 64.42B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-1.86% 47.43B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-9.53% 37.17B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-1.28% 34.81B
RESMED, INC. Stock ResMed, Inc.
+10.07% 27.46B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. EW Stock